Not All EVs Are Equal: Functional Heterogeneity of Extracellular Vesicles in Neuroregenerative Therapies
- 1Translational Platform for Regenerative Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawinskiego 5 Street, 02-106 Warsaw, Poland
Abstract
Extracellular vesicles (EVs) are increasingly being investigated as cell-free therapies for neurological diseases. However, their clinical application remains limited by biological and functional heterogeneity. EVs should therefore not be considered as a single, uniform therapeutic product defined only by their cell of origin, size, or conventional vesicle classification. EV composition and activity are influenced by extrinsic factors, including donor and tissue source, culture conditions, and isolation procedures, as well as by intrinsic mechanisms of vesicle biogenesis and selective cargo loading. Some vesicles may have beneficial therapeutic effects, whereas others may show little biological activity or act on unintended cellular targets. For this reason, EVs may be better classified according to biological function rather than only physical properties or cellular origin. A functionality-based classification could improve potency assessment, dose selection, reproducibility, and the development of consistent EV-based products. EV properties can be modulated by selecting appropriate parental cells, modifying culture conditions, or using genetic or metabolic engineering to alter EV production and cargo. Single-vesicle approaches can reveal differences between EV subpopulations and identify those responsible for specific biological effects. Overall, understanding EV heterogeneity may provide a rational basis for developing reproducible and disease-specific EV therapies for neurological and neurodegenerative disorders.
Related
- Extracellular vesicles in osteoarthritis: pathological mechanisms, regenerative therapies and clinical translation
- Split-intein-mediated engineering of VSV-G-free extracellular vesicles for enhanced cargo loading and delivery of functional proteins
- Next-Generation Functional Nanoplatforms: Engineering Plant-Derived Extracellular Vesicles for Targeted Bioactive Delivery and Health Applications
- Editorial: Investigating the role of extracellular vesicles in cardiovascular disease mechanisms
- ICAM-5: A marker for neuronally derived extracellular vesicles
BibTeX
@article{chodkowskamichalowska2026equal,
title = {{Not All EVs Are Equal: Functional Heterogeneity of Extracellular Vesicles in Neuroregenerative Therapies}},
author = {Magdalena Chodkowska-Michalowska and Oliwia Hawryluk and Szymon Lakomy and Anna Slysz and Anna Sarnowska},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219731},
url = {https://www.mdpi.com/1422-0067/27/21/9731},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Not All EVs Are Equal: Functional Heterogeneity of Extracellular Vesicles in Neuroregenerative Therapies
AU - Magdalena Chodkowska-Michalowska
AU - Oliwia Hawryluk
AU - Szymon Lakomy
AU - Anna Slysz
AU - Anna Sarnowska
PY - 2026
DA - 2026/10/30
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219731
UR - https://www.mdpi.com/1422-0067/27/21/9731
AB - Extracellular vesicles (EVs) are increasingly being investigated as cell-free therapies for neurological diseases. However, their clinical application remains limited by biological and functional heterogeneity. EVs should therefore not be considered as a single, uniform therapeutic product defined only by their cell of origin, size, or conventional vesicle classification. EV composition and activity are influenced by extrinsic factors, including donor and tissue source, culture conditions, and isolation procedures, as well as by intrinsic mechanisms of vesicle biogenesis and selective cargo loading. Some vesicles may have beneficial therapeutic effects, whereas others may show little biological activity or act on unintended cellular targets. For this reason, EVs may be better classified according to biological function rather than only physical properties or cellular origin. A functionality-based classification could improve potency assessment, dose selection, reproducibility, and the development of consistent EV-based products. EV properties can be modulated by selecting appropriate parental cells, modifying culture conditions, or using genetic or metabolic engineering to alter EV production and cargo. Single-vesicle approaches can reveal differences between EV subpopulations and identify those responsible for specific biological effects. Overall, understanding EV heterogeneity may provide a rational basis for developing reproducible and disease-specific EV therapies for neurological and neurodegenerative disorders.
SN - 1422-0067
ER -